These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29933083)

  • 21. Nonlinear optical properties of phenoxy-phthalocyanines at 800 nm with femtosecond pulse excitation.
    Ma L; Zhang Y; Yuan P
    Opt Express; 2010 Aug; 18(17):17666-71. PubMed ID: 20721153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo.
    Greene LM; Fleeton M; Mulligan J; Gowda C; Sheahan BJ; Atkins GJ; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
    Oncol Rep; 2005 Nov; 14(5):1357-63. PubMed ID: 16211309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of breast cancer cell lines by post-surgical drainage fluids.
    Ramolu L; Christ D; Abecassis J; Rodier JF
    Anticancer Res; 2014 Jul; 34(7):3489-92. PubMed ID: 24982358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
    Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of neoadjuvant chemotherapy on estrogen and progesterone receptors and P53 and CerbB-2 in breast cancer].
    Bao G; Yang DQ; Zhou B; Liu P; Wang S; Cheng L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2843-5. PubMed ID: 18167290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low temperature plasma suppresses proliferation, invasion, migration and survival of SK-BR-3 breast cancer cells.
    Li X; Sun T; Zhang X; Hou C; Shen Q; Wang D; Ni G
    Mol Biol Rep; 2023 Mar; 50(3):2025-2031. PubMed ID: 36538172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer amelioration by Butea monosperma in-vitro and in-vivo.
    Karia P; Patel KV; Rathod SSP
    J Ethnopharmacol; 2018 May; 217():54-62. PubMed ID: 29366766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
    Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
    BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of magnetic c-erbB-2 antisense probe of different concentrations on morphology and expression of SK-Br-3 cancer cell lines in vitro].
    Liu HY; Wen ZP; Wen M; He HR; Tan SD; Li SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):19-23. PubMed ID: 23469785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
    Kim J; Lee J; Kim C; Choi J; Kim A
    Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of expression of estrogen and progestrone receptors, human epithelial growth factor receptor 2 and Ki-67 after neoadjuvant chemotherapy in the treatment of breast cancer.
    Li ML; Dong Y; Luan SL; Zhao ZH; Ning FL
    J Biol Regul Homeost Agents; 2016; 30(4):1059-1065. PubMed ID: 28078854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status.
    Stark AM; Schem C; Maass N; Hugo HH; Jonat W; Mehdorn HM; Held-Feindt J
    Neurol Res; 2010 Apr; 32(3):303-8. PubMed ID: 19909580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6.
    Jensen BL; Skouv J; Lundholt BK; Lykkesfeldt AE
    Br J Cancer; 1999 Feb; 79(3-4):386-92. PubMed ID: 10027303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
    Ferrero-Poüs M; Hacène K; Bouchet C; Le Doussal V; Tubiana-Hulin M; Spyratos F
    Clin Cancer Res; 2000 Dec; 6(12):4745-54. PubMed ID: 11156229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and theoretical investigations of nonlinear optical properties of 1,4-Diamino-9,10-Anthraquionone.
    Zafar S; Khan ZH; Khan MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():164-9. PubMed ID: 23770504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Multicellular Breast Cancer Tumor Spheroids: Comparison of Different Protocols.
    Froehlich K; Haeger JD; Heger J; Pastuschek J; Photini SM; Yan Y; Lupp A; Pfarrer C; Mrowka R; Schleußner E; Markert UR; Schmidt A
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):89-98. PubMed ID: 27518775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients?
    Alimonti A; Ferretti G; Cognetti F
    J Clin Oncol; 2005 Dec; 23(34):8918; author reply 8918-9. PubMed ID: 16314657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.